Mersana Therapeutics Inc
NASDAQ:MRSN
Income Statement
Earnings Waterfall
Mersana Therapeutics Inc
Revenue
|
38.3m
USD
|
Operating Expenses
|
-181.2m
USD
|
Operating Income
|
-142.9m
USD
|
Other Expenses
|
8m
USD
|
Net Income
|
-134.8m
USD
|
Income Statement
Mersana Therapeutics Inc
Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||
Revenue |
25
N/A
|
26
+2%
|
23
-10%
|
26
+13%
|
18
-33%
|
16
-7%
|
17
+3%
|
13
-25%
|
11
-16%
|
49
+359%
|
45
-8%
|
43
-3%
|
42
-3%
|
1
-97%
|
2
+55%
|
1
-49%
|
1
-3%
|
1
N/A
|
0
-95%
|
0
N/A
|
0
N/A
|
2
+5 075%
|
6
+206%
|
12
+88%
|
27
+123%
|
32
+22%
|
39
+20%
|
41
+6%
|
37
-10%
|
38
+4%
|
|
Operating Income | |||||||||||||||||||||||||||||||
Operating Expenses |
(39)
|
(42)
|
(45)
|
(50)
|
(57)
|
(61)
|
(65)
|
(70)
|
(76)
|
(80)
|
(81)
|
(80)
|
(72)
|
(70)
|
(73)
|
(77)
|
(89)
|
(106)
|
(127)
|
(150)
|
(169)
|
(183)
|
(198)
|
(218)
|
(230)
|
(247)
|
(258)
|
(237)
|
(208)
|
(181)
|
|
Selling, General & Administrative |
(7)
|
(8)
|
(8)
|
(9)
|
(10)
|
(12)
|
(14)
|
(15)
|
(16)
|
(17)
|
(17)
|
(17)
|
(17)
|
(18)
|
(19)
|
(20)
|
(22)
|
(24)
|
(28)
|
(32)
|
(37)
|
(42)
|
(48)
|
(53)
|
(57)
|
(63)
|
(66)
|
(64)
|
(60)
|
(53)
|
|
Research & Development |
(31)
|
(35)
|
(37)
|
(41)
|
(47)
|
(49)
|
(51)
|
(55)
|
(60)
|
(63)
|
(64)
|
(62)
|
(55)
|
(52)
|
(54)
|
(57)
|
(67)
|
(82)
|
(99)
|
(118)
|
(132)
|
(140)
|
(150)
|
(165)
|
(173)
|
(185)
|
(193)
|
(172)
|
(148)
|
(120)
|
|
Depreciation & Amortization |
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(9)
|
|
Operating Income |
(14)
N/A
|
(17)
-20%
|
(22)
-32%
|
(24)
-10%
|
(40)
-65%
|
(44)
-12%
|
(48)
-8%
|
(57)
-20%
|
(66)
-15%
|
(31)
+52%
|
(37)
-16%
|
(36)
+0%
|
(30)
+17%
|
(69)
-128%
|
(71)
-3%
|
(76)
-7%
|
(88)
-16%
|
(106)
-20%
|
(127)
-20%
|
(150)
-18%
|
(169)
-13%
|
(181)
-7%
|
(192)
-6%
|
(206)
-7%
|
(204)
+1%
|
(215)
-6%
|
(220)
-2%
|
(196)
+11%
|
(171)
+13%
|
(143)
+16%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(0)
|
2
|
5
|
7
|
8
|
8
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
(9)
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(14)
N/A
|
(16)
-20%
|
(22)
-32%
|
(23)
-9%
|
(39)
-65%
|
(43)
-11%
|
(46)
-8%
|
(56)
-20%
|
(64)
-15%
|
(30)
+53%
|
(35)
-16%
|
(34)
+1%
|
(28)
+18%
|
(67)
-138%
|
(70)
-4%
|
(75)
-8%
|
(88)
-17%
|
(106)
-20%
|
(127)
-20%
|
(150)
-18%
|
(170)
-13%
|
(183)
-7%
|
(194)
-6%
|
(208)
-7%
|
(204)
+2%
|
(213)
-4%
|
(215)
-1%
|
(197)
+8%
|
(172)
+13%
|
(135)
+21%
|
|
Net Income | |||||||||||||||||||||||||||||||
Income from Continuing Operations |
(14)
|
(16)
|
(22)
|
(23)
|
(39)
|
(43)
|
(46)
|
(56)
|
(64)
|
(30)
|
(35)
|
(34)
|
(28)
|
(67)
|
(70)
|
(75)
|
(88)
|
(106)
|
(127)
|
(150)
|
(170)
|
(183)
|
(194)
|
(208)
|
(204)
|
(213)
|
(215)
|
(197)
|
(172)
|
(135)
|
|
Net Income (Common) |
(14)
N/A
|
(16)
-20%
|
(22)
-32%
|
(23)
-9%
|
(39)
-65%
|
(43)
-11%
|
(46)
-8%
|
(56)
-20%
|
(64)
-15%
|
(30)
+53%
|
(35)
-16%
|
(34)
+1%
|
(28)
+18%
|
(67)
-138%
|
(70)
-4%
|
(75)
-8%
|
(88)
-17%
|
(106)
-20%
|
(127)
-20%
|
(150)
-18%
|
(170)
-13%
|
(183)
-7%
|
(194)
-6%
|
(208)
-7%
|
(204)
+2%
|
(213)
-4%
|
(215)
-1%
|
(197)
+8%
|
(172)
+13%
|
(135)
+21%
|
|
EPS (Diluted) |
-0.6
N/A
|
-0.73
-22%
|
-0.95
-30%
|
-1.03
-8%
|
-1.7
-65%
|
-1.88
-11%
|
-2.03
-8%
|
-2.4
-18%
|
-2.79
-16%
|
-0.95
+66%
|
-0.72
+24%
|
-0.71
+1%
|
-0.65
+8%
|
-1.4
-115%
|
-1.14
+19%
|
-1.1
+4%
|
-1.43
-30%
|
-1.53
-7%
|
-1.84
-20%
|
-2.08
-13%
|
-2.41
-16%
|
-2.28
+5%
|
-2.02
+11%
|
-2.13
-5%
|
-2.18
-2%
|
-1.98
+9%
|
-1.86
+6%
|
-1.63
+12%
|
-1.48
+9%
|
-1.11
+25%
|